Carl Zeiss Meditec AG (XSWX:AFX) Cash Flow for Lease Financing: CHF0 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:AFX Carl Zeiss Meditec AG XSWX:AFX
78 GF Score
Price CHF29.36
GF Value CHF71.65
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG Cash Flow for Lease Financing?

Carl Zeiss Meditec AG XSWX:AFX -1.41% 78 Cash Flow for Lease Financing is CHF0 Mil as of Sep. 2025. GuruFocus rates XSWX:AFX with a GF Score™ of 78/100 and a GF Value™ of CHF71.65. The stock has 4 warning signs investors should review.

Carl Zeiss Meditec AG's Cash Flow for Lease Financing for the six months ended in Sep. 2025 was CHF0 Mil. Carl Zeiss Meditec AG's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Sep. 2025 was CHF0 Mil.

Compared with last quarter (CHF0 Mil in Mar. 2025 ), Carl Zeiss Meditec AG's Cash Flow for Lease Financing remained the same in Sep. 2025 (CHF0 Mil).

Carl Zeiss Meditec AG Cash Flow for Lease Financing Historical Data

* Premium members only.

The historical data trend for Carl Zeiss Meditec AG's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG Cash Flow for Lease Financing Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.93 -19.18 -22.07 -21.91 -21.83

Carl Zeiss Meditec AG Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:AFX
78GF Score
Carl Zeiss Meditec AG XSWX:AFX
Cash Flow for Lease Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carl Zeiss Meditec AG Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Lease Financing of CHF0 Mil mean?
Carl Zeiss Meditec AG (XSWX:AFX) has a Cash Flow for Lease Financing of CHF0 Mil as of Sep. 2025. Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing. View historical data on Carl Zeiss Meditec AG and its competitors.
Is Carl Zeiss Meditec AG's Cash Flow for Lease Financing too high?
Carl Zeiss Meditec AG's current Cash Flow for Lease Financing is CHF0 Mil. Overall, Carl Zeiss Meditec AG has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Cash Flow for Lease Financing compare to ISRG and BDX?
Carl Zeiss Meditec AG's Cash Flow for Lease Financing of CHF0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Lease Financing for a Medical Devices & Instruments company?
A good Cash Flow for Lease Financing depends on the Medical Devices & Instruments industry context. However, Cash Flow for Lease Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Lease Financing mean?
A high Cash Flow for Lease Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing. View historical data on Carl Zeiss Meditec AG and its competitors. Carl Zeiss Meditec AG's current Cash Flow for Lease Financing is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Carl Zeiss Meditec AG (XSWX:AFX) has a current Cash Flow for Lease Financing of CHF0 Mil. The stock's GF Value™ is CHF71.65, compared to a current price of CHF29.36 — trading 59% below its estimated fair value. The current Cash Flow for Lease Financing is CHF0 Mil. Carl Zeiss Meditec AG's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Lease Financing calculated?
Cash Flow for Lease Financing is calculated from a company's financial statements. For Carl Zeiss Meditec AG (XSWX:AFX), the current Cash Flow for Lease Financing is CHF0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of CHF29.36 is trading 59% below its estimated GF Value™ of CHF71.65.

Key valuation signals for XSWX:AFX:

  • Cash Flow for Lease Financing: CHF0 Mil
  • GF Value™: CHF71.65 vs. price of CHF29.36 (59% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
78GF Score

Get the complete analysis for XSWX:AFX

Cash Flow for Lease Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF29.36
Price
CHF71.65
GF Value